Mark E. Dunlap, MD

Article

Angiotensin-receptor blockers in heart failure: Evidence from the CHARM trial

Author:: Mark E. Dunlap, MD

Publish date: August 1, 2004

The ARB candesartan was not only a good alternative to an ACE inhibitor, it was beneficial when added to a regimen that already included an ACE inh...

Article

ACE inhibitors vs ARBs: Is one class better for heart failure

Author:: Mark E. Dunlap, MD

Publish date: May 1, 2002

A patient who apparently cannot tolerate ACE inhibitors presents with worsening heart failure. What should be the next step?